Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 2
1965 1
1967 1
1968 1
1969 4
1970 1
1973 1
1974 1
1978 2
1979 2
1980 2
1981 3
1982 5
1983 2
1984 8
1985 3
1986 6
1987 6
1988 8
1989 9
1990 6
1991 6
1992 5
1993 11
1994 6
1995 14
1996 14
1997 10
1998 15
1999 24
2000 17
2001 9
2002 12
2003 14
2004 17
2005 5
2006 8
2007 16
2008 9
2009 14
2010 9
2011 20
2012 24
2013 19
2014 25
2015 31
2016 16
2017 14
2018 24
2019 19
2020 18
2021 25
2022 26
2023 9

Text availability

Article attribute

Article type

Publication date

Search Results

539 results

Results by year

Filters applied: . Clear all
Page 1
First-in-Human Phase 1 Study of MORAb-202, an Antibody-Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α-Positive Advanced Solid Tumors.
Shimizu T, Fujiwara Y, Yonemori K, Koyama T, Sato J, Tamura K, Shimomura A, Ikezawa H, Nomoto M, Furuuchi K, Nakajima R, Miura T, Yamamoto N. Shimizu T, et al. Among authors: nomoto m. Clin Cancer Res. 2021 Jul 15;27(14):3905-3915. doi: 10.1158/1078-0432.CCR-20-4740. Epub 2021 Apr 29. Clin Cancer Res. 2021. PMID: 33926914 Clinical Trial.
Levodopa-induced dyskinesias.
Fabbrini G, Brotchie JM, Grandas F, Nomoto M, Goetz CG. Fabbrini G, et al. Among authors: nomoto m. Mov Disord. 2007 Jul 30;22(10):1379-1389. doi: 10.1002/mds.21475. Mov Disord. 2007. PMID: 17427940 Review.
Efficacy and safety of safinamide as an add-on therapy to L-DOPA for patients with Parkinson's disease: A randomized, double-blind, placebo-controlled, phase II/III study.
Hattori N, Tsuboi Y, Yamamoto A, Sasagawa Y, Nomoto M; ME2125-3 Study Group. Hattori N, et al. Among authors: nomoto m. Parkinsonism Relat Disord. 2020 Jun;75:17-23. doi: 10.1016/j.parkreldis.2020.04.012. Epub 2020 May 4. Parkinsonism Relat Disord. 2020. PMID: 32446176 Free article. Clinical Trial.
Management of neuropathic pain.
Nishikawa N, Nomoto M. Nishikawa N, et al. Among authors: nomoto m. J Gen Fam Med. 2017 Apr 12;18(2):56-60. doi: 10.1002/jgf2.5. eCollection 2017 Apr. J Gen Fam Med. 2017. PMID: 29263992 Free PMC article. Review.
Delayed L-DOPA-induced hyperalgesia.
Shimizu T, Iwata S, Miyata A, Fukuda T, Nomoto M. Shimizu T, et al. Among authors: nomoto m. Pharmacol Biochem Behav. 2006 Nov;85(3):643-7. doi: 10.1016/j.pbb.2006.10.020. Epub 2006 Dec 4. Pharmacol Biochem Behav. 2006. PMID: 17141847
Behavioral, cellular, and synaptic tagging frameworks.
Nomoto M, Inokuchi K. Nomoto M, et al. Neurobiol Learn Mem. 2018 Sep;153(Pt A):13-20. doi: 10.1016/j.nlm.2018.03.010. Epub 2018 Mar 10. Neurobiol Learn Mem. 2018. PMID: 29535042 Review.
Ventricular Assist Device-Induced Ventricular Septal Perforation.
Hoki R, Kikuchi N, Nomoto M, Hattori H, Ichihara Y, Yamada Y, Saito S, Nunoda S, Hagiwara N, Niinami H. Hoki R, et al. Among authors: nomoto m. Circ J. 2022 Jul 25;86(8):1307. doi: 10.1253/circj.CJ-21-0742. Epub 2022 Feb 16. Circ J. 2022. PMID: 35173092 Free article. No abstract available.
Diagnostic imaging of hepatic lymphoma.
Abe H, Kamimura K, Kawai H, Kamimura H, Domori K, Kobayashi Y, Nomoto M, Aoyagi Y. Abe H, et al. Among authors: nomoto m. Clin Res Hepatol Gastroenterol. 2015 Sep;39(4):435-42. doi: 10.1016/j.clinre.2014.11.001. Epub 2014 Dec 23. Clin Res Hepatol Gastroenterol. 2015. PMID: 25541481 Review.
First case of Myhre syndrome with schizophrenia.
Inoue K, Eiro T, Semoto M, Roppongi T, Nomoto M, Takahashi Y, Hishimoto A. Inoue K, et al. Among authors: nomoto m. Clin Dysmorphol. 2021 Oct 1;30(4):207-208. doi: 10.1097/MCD.0000000000000386. Clin Dysmorphol. 2021. PMID: 34456243 No abstract available.
539 results